PeptiDream Inc. (4587.T)
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
947.20+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-43.3%
The outlook
PeptiDream Inc. currently reads as neutral based on strong buy — 1.5 avg of 6 analysts, below its 50- & 200-day averages, 3% of the way from its 52-week low to high, avg target +190% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 6 analysts
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Price targetAvg target +190% vs current price
Analyst price target
~12-month · 6 analysts2,750.00average target+190.3% vs now
Now 947.20
Low 1,100.00High 4,400.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$121.71B
52-wk high
1,818.50
52-wk low
916.00
50-day avg
1,017.99
200-day avg
1,354.02
Trailing P/E
—